ClinConnect ClinConnect Logo
Search / Trial NCT06288477

Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol

Launched by OCTOBER UNIVERSITY FOR MODERN SCIENCES AND ARTS · Feb 23, 2024

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new treatment for children with healthy primary molars (the back teeth) that need a procedure called vital pulpotomy, which helps preserve the tooth's nerve. The study is comparing a novel medication called Neo-putty, made from bioactive bioceramic materials, against a traditional treatment known as formocresol. While formocresol has been commonly used, it can sometimes cause harmful side effects, and researchers want to see if Neo-putty can be a safer alternative.

To participate in this trial, children aged 4 to 9 years old with specific dental conditions may be eligible. They must have primary molars that are healthy, without pain, and with enough root length remaining. However, children with certain health issues or uncooperative behavior, or those with teeth that cannot be saved, will not be included. Participants can expect to receive one of the two treatments and be monitored during the study to see how well each treatment works and how safe it is. This research aims to find the best way to care for young patients’ teeth while minimizing risks.

Gender

ALL

Eligibility criteria

  • Criteria The eligibility criteria were set according to the guidelines of AAPD, 2020. (4)
  • Inclusion Criteria:
  • 1. 4 -9 years old
  • 2. Primary molars with no spontaneous or provoked pain
  • 3. Primary molars with at least two-thirds of the root length were still present.
  • 4. Primary molars with no sign of internal or other kinds of root or bone resorption.
  • Exclusion Criteria:
  • 1. Patients with systemic diseases (congenital or rheumatic heart disease, hepatitis, nephritis, tumor, cyclic neutropenia, leukemia, and children on long-term corticosteroid therapy).
  • 2. Un-cooperative patients.
  • 3. Un-restorable primary molars (Grossly broken-down primary molars that have decay extending way under the gingiva and tooth with root caries).

About October University For Modern Sciences And Arts

October University for Modern Sciences and Arts (MSA) is a leading academic institution in Egypt, dedicated to advancing education and research in various fields, including health sciences. The university is committed to fostering innovation and excellence in clinical research, aiming to enhance healthcare outcomes through rigorous scientific inquiry. With a focus on collaboration between academia and industry, MSA actively sponsors clinical trials that address critical health challenges, ensuring adherence to ethical standards and regulatory compliance. By leveraging its multidisciplinary expertise and state-of-the-art facilities, MSA strives to contribute significantly to the body of medical knowledge and improve patient care.

Locations

El Sheikh Zayed City, Giza, Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported